NEW YORK, April 17, 2020 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced the addition of two independent members, Mr. Graig Springer and Mr. Wayne Linsley, to its Board of Directors. The Company also announced the resignation of current board member, Mr. Anthony Hayes.

(PRNewsfoto/Hoth Therapeutics Inc.)

“Management is pleased to announce the addition of two experienced and successful leaders to our Board,” said Mr. Robb Knie, Chief Executive Officer of Hoth Therapeutics. “I am confident that their experience in business management, financial reporting and capital markets will serve us well as we continue our growth and development.  We look forward to leveraging their insights and experience.”

Mr. Knie continued, “Anthony Hayes has been a trusted colleague and advisor for many years. On behalf of my fellow directors, the company’s

Read More At Article Source | Article Attribution